Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ·Healthcare·Biotechnology
$226.51
—
Mkt Cap $30.46B
Analyst Ratings
Buy
24
Hold
7
Sell
0
Price Target (87 analysts)
$347.33
Range $256.00 – $455.00
Implied Upside
+53.3%
Consensus $347.33 vs current $226.51
NASDAQ·Healthcare·Biotechnology
$226.51
—
Mkt Cap $30.46B
Buy
24
Hold
7
Sell
0
Price Target (87 analysts)
$347.33
Range $256.00 – $455.00
+53.3%
Consensus $347.33 vs current $226.51